Point72 Asia (Singapore) Pte. Ltd. Guardant Health, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $379 Billion
- Q4 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 2,004 shares of GH stock, worth $81,642. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,004Holding current value
$81,642% of portfolio
0.02%Shares
2 transactions
Others Institutions Holding GH
# of Institutions
347Shares Held
120MCall Options Held
793KPut Options Held
1.85M-
Vanguard Group Inc Valley Forge, PA12.1MShares$491 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$458 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$262 Million8.64% of portfolio
-
Baillie Gifford & CO5.45MShares$222 Million0.13% of portfolio
-
Cadian Capital Management, LP New York, NY5.22MShares$213 Million9.25% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.16B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...